Immune Axonal Neuropathies Associated With Systemic Autoimmune Rheumatic Diseases

被引:14
|
作者
Tulba, Delia [1 ,2 ,3 ]
Popescu, Bogdan Ovidiu [1 ,3 ,4 ]
Manole, Emilia [4 ]
Baicus, Cristian [2 ,3 ,5 ]
机构
[1] Colentina Clin Hosp, Dept Neurol, Bucharest, Romania
[2] Colentina Clin Hosp, Colentina Res & Dev Ctr, Bucharest, Romania
[3] Carol Davila Univ Med & Pharm, Bucharest, Romania
[4] Victor Babes Natl Inst Pathol, Lab Cell Biol Neurosci & Expt Myol, Bucharest, Romania
[5] Colentina Clin Hosp, Dept Internal Med, Bucharest, Romania
关键词
immune axonal neuropathy; vasculitic neuropathy; sensorimotor polyneuropathy; mononeuritis multiplex; connective tissue disease; systemic vasculitis; systemic autoimmune rheumatic disease; small fiber neuropathy; HIGH-RESOLUTION SONOGRAPHY; ANCA-ASSOCIATED VASCULITIS; PERIPHERAL NEUROPATHY; LUPUS-ERYTHEMATOSUS; INTRAVENOUS CYCLOPHOSPHAMIDE; CLINICOPATHOLOGICAL FEATURES; NEUROLOGICAL MANIFESTATIONS; NERVOUS-SYSTEM; 1990; CRITERIA; CLASSIFICATION;
D O I
10.3389/fphar.2021.610585
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Immune axonal neuropathies are a particular group of immune-mediated neuropathies that occasionally accompany systemic autoimmune rheumatic diseases such as connective tissue dissorders and primary systemic vasculitides. Apart from vasculitis of vasa nervorum, various other mechanisms are involved in their pathogenesis, with possible therapeutic implications. Immune axonal neuropathies have highly heterogeneous clinical presentation and course, ranging from mild chronic distal sensorimotor polyneuropathy to severe subacute mononeuritis multiplex with rapid progression and constitutional symptoms such as fever, malaise, weight loss and night sweats, underpinning a vasculitic process. Sensory neuronopathy (ganglionopathy), small fiber neuropathy (sensory and/or autonomic), axonal variants of Guillain-Barre syndrome and cranial neuropathies have also been reported. In contrast to demyelinating neuropathies, immune axonal neuropathies show absent or reduced nerve amplitudes with normal latencies and conduction velocities on nerve conduction studies. Diagnosis and initiation of treatment are often delayed, leading to accumulating disability. Considering the lack of validated diagnostic criteria and evidence-based treatment protocols for immune axonal neuropathies, this review offers a comprehensive perspective on etiopathogenesis, clinical and paraclinical findings as well as therapy guidance for assisting the clinician in approaching these patients. High quality clinical research is required in order to provide indications and follow up rules for treatment in immune axonal neuropathies related to systemic autoimmune rheumatic diseases.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Rituximab in systemic autoimmune rheumatic diseases: indications and practical use
    Berghen, Nathalie
    Vulsteke, Jean-Baptiste
    Westhovens, Rene
    Lenaerts, Jan
    De Langhe, Ellen
    ACTA CLINICA BELGICA, 2019, 74 (04) : 272 - 279
  • [42] The Impact of Statin Use on Mortality in Systemic Autoimmune Rheumatic Diseases
    Jorge, April
    Lu, Na
    Choi, Hyon K.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [43] Neuromyelitis optica spectrum standstill in rheumatic systemic autoimmune diseases
    Elnady, Basant
    Fathy, Sabry M.
    Elkhouly, Tohamy
    Ganeb, Sahar
    EGYPTIAN RHEUMATOLOGY AND REHABILITATION, 2020, 47 (01)
  • [44] Adipokines: Some players of inflammation in inflammatory rheumatic diseases and systemic autoimmune diseases?
    Toussirot, Eric
    PRESSE MEDICALE, 2013, 42 (01): : 13 - 18
  • [45] Autoimmune Rheumatic Diseases 1 Clinical aspects of autoimmune rheumatic diseases
    Goldblatt, Fiona
    O'Neill, Sean G.
    LANCET, 2013, 382 (9894): : 797 - 808
  • [46] Prevalence of Neuropathies in Rheumatic and Musculoskeletal Diseases
    Hasseli, Rebecca
    Tschernatsch, Marlene
    Heimann, Neele
    Neumann, Elena
    Gerriets, Tibo
    Allendoerfer, Jens
    Ruck, Tobias
    Mueler-Ladner, Ulf
    Schaenzer, Anne
    Hasseli, Rebecca
    INTERNIST, 2021, 62 (SUPPL 2): : 184 - 184
  • [47] PREVALENCE OF NEUROPATHIES IN RHEUMATIC AND MUSCULOSKELETAL DISEASES
    Hasseli, R.
    Tschernatsch, M.
    Heimann, N.
    Neumann, E.
    Gerriets, T.
    Allendoerfer, J.
    Ruck, T.
    Schaenzer, A.
    Mueller-Ladner, U.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 209 - 209
  • [48] MONOCYTE ACTIVATION IN ATHEROSCLEROSIS ASSOCIATED WITH AUTOIMMUNE RHEUMATIC DISEASES
    Kirichenko, T. V.
    Gerasimova, E. V.
    Popkova, T. V.
    Markin, A. M.
    Markina, Y. V.
    Bogatyreva, A. I.
    Gerasimova, D. A.
    Orekhov, A. N.
    ATHEROSCLEROSIS, 2022, 355 : E102 - E102
  • [49] Autoimmune Rheumatic Diseases
    Anaya, Juan-Manuel
    Shoenfeld, Yehuda
    Buttgereit, Frank
    Gonzalez-Gay, Miguel A.
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [50] Factors associated with incident severe pulmonary arterial hypertension in systemic autoimmune rheumatic diseases: a nationwide study
    Chen, Hsin-Hua
    Lin, Ching-Heng
    Hsieh, Tsu-Yi
    Chen, Der-Yuan
    Ying, Jia-Ching
    Chao, Wen-Cheng
    RHEUMATOLOGY, 2021, 60 (11) : 5351 - 5361